<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-10-18" modified="2017-12-20" version="160">
<accession>Q15125</accession>
<accession>Q6FGL3</accession>
<accession>Q6IBI9</accession>
<name>EBP_HUMAN</name>
<protein>
<recommendedName>
<fullName>3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase</fullName>
<ecNumber evidence="10 16 17">5.3.3.5</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cholestenol Delta-isomerase</fullName>
</alternativeName>
<alternativeName>
<fullName>Delta(8)-Delta(7) sterol isomerase</fullName>
<shortName>D8-D7 sterol isomerase</shortName>
</alternativeName>
<alternativeName>
<fullName>Emopamil-binding protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">EBP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="7551" last="7557">
<title>Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression.</title>
<authorList>
<person name="Hanner M."/>
<person name="Moebius F.F."/>
<person name="Weber F."/>
<person name="Grabner M."/>
<person name="Striessnig J."/>
<person name="Glossmann H."/>
</authorList>
<dbReference type="PubMed" id="7706302"/>
<dbReference type="DOI" id="10.1074/jbc.270.13.7551"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="22434" last="22440">
<title>Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast.</title>
<authorList>
<person name="Silve S."/>
<person name="Dupuy P.H."/>
<person name="Labit-Lebouteiller C."/>
<person name="Kaghad M."/>
<person name="Chalon P."/>
<person name="Rahier A."/>
<person name="Taton M."/>
<person name="Lupker J."/>
<person name="Shire D."/>
<person name="Loison G."/>
</authorList>
<dbReference type="PubMed" id="8798407"/>
<dbReference type="DOI" id="10.1074/jbc.271.37.22434"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="Biochemistry" volume="38" first="1119" last="1127">
<title>Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization.</title>
<authorList>
<person name="Moebius F.F."/>
<person name="Soellner K.E.M."/>
<person name="Fiechtner B."/>
<person name="Huck C.W."/>
<person name="Bonn G."/>
<person name="Glossmann H."/>
</authorList>
<dbReference type="PubMed" id="9894009"/>
<dbReference type="DOI" id="10.1021/bi981804i"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>PATHWAY</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Eur. J. Biochem." volume="263" first="377" last="386">
<title>Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level.</title>
<authorList>
<person name="Dussossoy D."/>
<person name="Carayon P."/>
<person name="Belugou S."/>
<person name="Feraut D."/>
<person name="Bord A."/>
<person name="Goubet C."/>
<person name="Roque C."/>
<person name="Vidal H."/>
<person name="Combes T."/>
<person name="Loison G."/>
<person name="Casellas P."/>
</authorList>
<dbReference type="PubMed" id="10406945"/>
<dbReference type="DOI" id="10.1046/j.1432-1327.1999.00500.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Am. J. Med. Genet. A" volume="116A" first="249" last="254">
<title>Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP.</title>
<authorList>
<person name="Milunsky J.M."/>
<person name="Maher T.A."/>
<person name="Metzenberg A.B."/>
</authorList>
<dbReference type="PubMed" id="12503101"/>
<dbReference type="DOI" id="10.1002/ajmg.a.10849"/>
</citation>
<scope>INVOLVEMENT IN MEND</scope>
<scope>VARIANT MEND PRO-18</scope>
<scope>CHARACTERIZATION OF VARIANT MEND PRO-18</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Biochem. J." volume="374" first="229" last="237">
<title>Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity.</title>
<authorList>
<person name="Moebius F.F."/>
<person name="Fitzky B.U."/>
<person name="Wietzorrek G."/>
<person name="Haidekker A."/>
<person name="Eder A."/>
<person name="Glossmann H."/>
</authorList>
<dbReference type="PubMed" id="12760743"/>
<dbReference type="DOI" id="10.1042/BJ20030465"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>PATHWAY</scope>
<scope>MUTAGENESIS OF TYR-111; MET-121 AND PHE-189</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2010" name="Am. J. Med. Genet. A" volume="152A" first="2838" last="2844">
<title>A novel X-linked multiple congenital anomaly syndrome associated with an EBP mutation.</title>
<authorList>
<person name="Furtado L.V."/>
<person name="Bayrak-Toydemir P."/>
<person name="Hulinsky B."/>
<person name="Damjanovich K."/>
<person name="Carey J.C."/>
<person name="Rope A.F."/>
</authorList>
<dbReference type="PubMed" id="20949533"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33674"/>
</citation>
<scope>INVOLVEMENT IN MEND</scope>
<scope>VARIANT MEND CYS-47</scope>
<scope>CHARACTERIZATION OF VARIANT MEND CYS-47</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="286" last="290">
<title>Mutations in a delta(8)-delta(7) sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata.</title>
<authorList>
<person name="Derry J.M.J."/>
<person name="Gormally E."/>
<person name="Means G.D."/>
<person name="Zhao W."/>
<person name="Meindl A."/>
<person name="Kelley R.I."/>
<person name="Boyd Y."/>
<person name="Herman G.E."/>
</authorList>
<dbReference type="PubMed" id="10391218"/>
<dbReference type="DOI" id="10.1038/10350"/>
</citation>
<scope>VARIANT CDPX2 GLN-110</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="291" last="294">
<title>Mutations in the gene encoding 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase cause X-linked dominant Conradi-Hunermann syndrome.</title>
<authorList>
<person name="Braverman N."/>
<person name="Lin P."/>
<person name="Moebius F.F."/>
<person name="Obie C."/>
<person name="Moser A."/>
<person name="Glossmann H."/>
<person name="Wilcox W.R."/>
<person name="Rimoin D.L."/>
<person name="Smith M."/>
<person name="Kratz L."/>
<person name="Kelley R.I."/>
<person name="Valle D."/>
</authorList>
<dbReference type="PubMed" id="10391219"/>
<dbReference type="DOI" id="10.1038/10357"/>
</citation>
<scope>VARIANTS CDPX2 LYS-80 AND HIS-147</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="1951" last="1955">
<title>The Conradi-Hunermann-Happle syndrome (CDPX2) and emopamil binding protein: novel mutations, and somatic and gonadal mosaicism.</title>
<authorList>
<person name="Has C."/>
<person name="Bruckner-Tuderman L."/>
<person name="Muller D."/>
<person name="Floeth M."/>
<person name="Folkers E."/>
<person name="Donnai D."/>
<person name="Traupe H."/>
</authorList>
<dbReference type="PubMed" id="10942423"/>
<dbReference type="DOI" id="10.1093/hmg/9.13.1951"/>
</citation>
<scope>VARIANT CDPX2 HIS-147</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Exp. Dermatol." volume="10" first="286" last="289">
<title>Identification of a novel mutation in 3beta-hydroxysteroid-Delta8-Delta7-isomerase in a case of Conradi-Hunermann-Happle syndrome.</title>
<authorList>
<person name="Becker K."/>
<person name="Csikos M."/>
<person name="Horvath A."/>
<person name="Karpati S."/>
</authorList>
<dbReference type="PubMed" id="11493318"/>
<dbReference type="DOI" id="10.1034/j.1600-0625.2001.100409.x"/>
</citation>
<scope>VARIANT CDPX2 GLY-147</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Acta Derm. Venereol." volume="88" first="47" last="51">
<title>Conradi-Huenermann-Happle syndrome (X-linked dominant chondrodysplasia punctata) confirmed by plasma sterol and mutation analysis.</title>
<authorList>
<person name="Kolb-Maeurer A."/>
<person name="Grzeschik K.H."/>
<person name="Haas D."/>
<person name="Broecker E.B."/>
<person name="Hamm H."/>
</authorList>
<dbReference type="PubMed" id="18176751"/>
<dbReference type="DOI" id="10.2340/00015555-0337"/>
</citation>
<scope>VARIANT CDPX2 LYS-103</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="Am. J. Med. Genet. A" volume="164A" first="907" last="914">
<title>An unusual phenotype of X-linked developmental delay and extreme behavioral difficulties associated with a mutation in the EBP gene.</title>
<authorList>
<person name="Hartill V.L."/>
<person name="Tysoe C."/>
<person name="Manning N."/>
<person name="Dobbie A."/>
<person name="Santra S."/>
<person name="Walter J."/>
<person name="Caswell R."/>
<person name="Koster J."/>
<person name="Waterham H."/>
<person name="Hobson E."/>
</authorList>
<dbReference type="PubMed" id="24459067"/>
<dbReference type="DOI" id="10.1002/ajmg.a.36368"/>
</citation>
<scope>VARIANT MEND ARG-47</scope>
<scope>CHARACTERIZATION OF VARIANT MEND ARG-47</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="Am. J. Med. Genet. A" volume="164A" first="1642" last="1647">
<title>A novel EBP c.224T>A mutation supports the existence of a male-specific disorder independent of CDPX2.</title>
<authorList>
<person name="Barboza-Cerda M.C."/>
<person name="Wong L.J."/>
<person name="Martinez-de-Villarreal L.E."/>
<person name="Zhang V.W."/>
<person name="Dector M.A."/>
</authorList>
<dbReference type="PubMed" id="24700572"/>
<dbReference type="DOI" id="10.1002/ajmg.a.36508"/>
</citation>
<scope>VARIANT MEND ASN-75</scope>
<scope>CHARACTERIZATION OF VARIANT MEND ASN-75</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2015" name="Indian J. Dermatol." volume="60" first="216" last="216">
<title>Emopamil binding protein mutation in conradi-huenermann-happle syndrome representing plaque-type psoriasis.</title>
<authorList>
<person name="Ozyurt K."/>
<person name="Subasioglu A."/>
<person name="Ozturk P."/>
<person name="Inci R."/>
<person name="Ozkan F."/>
<person name="Bueno E."/>
<person name="Canueto J."/>
<person name="Gonzalez Sarmiento R."/>
</authorList>
<dbReference type="PubMed" id="25814754"/>
<dbReference type="DOI" id="10.4103/0019-5154.152570"/>
</citation>
<scope>VARIANT CDPX2 HIS-147</scope>
</reference>
<comment type="function">
<text evidence="10 16 17">Catalyzes the conversion of Delta(8)-sterols to their corresponding Delta(7)-isomers.</text>
</comment>
<comment type="catalytic activity">
<text evidence="10 16 17">5-alpha-cholest-7-en-3-beta-ol = 5-alpha-cholest-8-en-3-beta-ol.</text>
</comment>
<comment type="pathway" evidence="10 16 17">
<text>Steroid biosynthesis; cholesterol biosynthesis.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3915253"/>
<interactant intactId="EBI-625022">
<id>O43889-2</id>
<label>CREB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-3915253"/>
<interactant intactId="EBI-6942903">
<id>Q96BA8</id>
<label>CREB3L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="6">Endoplasmic reticulum membrane</location>
<topology evidence="18">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Nucleus envelope</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Cytoplasmic vesicle</location>
</subcellularLocation>
<text evidence="6">During interphase, detected on the endoplasmic reticulum and the nuclear envelope. During mitosis, detected on cytoplasmic vesicles.</text>
</comment>
<comment type="disease" evidence="4 5 7 8 11 15">
<disease id="DI-00303">
<name>Chondrodysplasia punctata 2, X-linked dominant</name>
<acronym>CDPX2</acronym>
<description>A clinically and genetically heterogeneous disorder characterized by punctiform calcification of the bones. The key clinical features of CDPX2 are chondrodysplasia punctata, linear ichthyosis, cataracts and short stature. CDPX2 is a rare disorder of defective cholesterol biosynthesis, biochemically characterized by an increased amount of 8-dehydrocholesterol and cholest-8(9)-en-3-beta-ol in the plasma and tissues.</description>
<dbReference type="MIM" id="302960"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="9 12 13 14">
<disease id="DI-04527">
<name>MEND syndrome</name>
<acronym>MEND</acronym>
<description>An X-linked recessive disorder associated with a defect in sterol biosynthesis. Disease manifestations and severity are highly variable. Clinical features include intellectual disability, short stature, scoliosis, digital abnormalities, cataracts, and dermatologic abnormalities.</description>
<dbReference type="MIM" id="300960"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Binds to the phenylalkylamine calcium-ion antagonist emopamil, an anti-ischemic drug.</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the EBP family.</text>
</comment>
<dbReference type="EC" id="5.3.3.5" evidence="10 16 17"/>
<dbReference type="EMBL" id="Z37986">
<property type="protein sequence ID" value="CAA86068.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR456815">
<property type="protein sequence ID" value="CAG33096.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR542094">
<property type="protein sequence ID" value="CAG46891.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF196969">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF196972">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471224">
<property type="protein sequence ID" value="EAW50773.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001549">
<property type="protein sequence ID" value="AAH01549.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001572">
<property type="protein sequence ID" value="AAH01572.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC046501">
<property type="protein sequence ID" value="AAH46501.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14300.1"/>
<dbReference type="PIR" id="B56122">
<property type="entry name" value="B56122"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006570.1">
<property type="nucleotide sequence ID" value="NM_006579.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.30619"/>
<dbReference type="ProteinModelPortal" id="Q15125"/>
<dbReference type="BioGrid" id="115921">
<property type="interactions" value="39"/>
</dbReference>
<dbReference type="IntAct" id="Q15125">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000417052"/>
<dbReference type="BindingDB" id="Q15125"/>
<dbReference type="ChEMBL" id="CHEMBL4931"/>
<dbReference type="DrugBank" id="DB00675">
<property type="generic name" value="Tamoxifen"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000001209"/>
<dbReference type="iPTMnet" id="Q15125"/>
<dbReference type="PhosphoSitePlus" id="Q15125"/>
<dbReference type="BioMuta" id="EBP"/>
<dbReference type="DMDM" id="17374795"/>
<dbReference type="EPD" id="Q15125"/>
<dbReference type="MaxQB" id="Q15125"/>
<dbReference type="PaxDb" id="Q15125"/>
<dbReference type="PeptideAtlas" id="Q15125"/>
<dbReference type="PRIDE" id="Q15125"/>
<dbReference type="TopDownProteomics" id="Q15125"/>
<dbReference type="DNASU" id="10682"/>
<dbReference type="Ensembl" id="ENST00000495186">
<property type="protein sequence ID" value="ENSP00000417052"/>
<property type="gene ID" value="ENSG00000147155"/>
</dbReference>
<dbReference type="GeneID" id="10682"/>
<dbReference type="KEGG" id="hsa:10682"/>
<dbReference type="UCSC" id="uc004djx.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10682"/>
<dbReference type="DisGeNET" id="10682"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000147155.10"/>
<dbReference type="GeneCards" id="EBP"/>
<dbReference type="GeneReviews" id="EBP"/>
<dbReference type="HGNC" id="HGNC:3133">
<property type="gene designation" value="EBP"/>
</dbReference>
<dbReference type="HPA" id="HPA003130"/>
<dbReference type="MalaCards" id="EBP"/>
<dbReference type="MIM" id="300205">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="300960">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="302960">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15125"/>
<dbReference type="OpenTargets" id="ENSG00000147155"/>
<dbReference type="Orphanet" id="352487">
<property type="disease" value="Digital anomalies - intellectual disability - short stature"/>
</dbReference>
<dbReference type="Orphanet" id="401973">
<property type="disease" value="MEND syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="35173">
<property type="disease" value="X-linked dominant chondrodysplasia punctata"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27587"/>
<dbReference type="eggNOG" id="KOG4826">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG41101ES">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063715"/>
<dbReference type="HOGENOM" id="HOG000204543"/>
<dbReference type="HOVERGEN" id="HBG018176"/>
<dbReference type="InParanoid" id="Q15125"/>
<dbReference type="KO" id="K01824"/>
<dbReference type="OMA" id="SPLHPYW"/>
<dbReference type="OrthoDB" id="EOG091G0KCI"/>
<dbReference type="PhylomeDB" id="Q15125"/>
<dbReference type="TreeFam" id="TF314716"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000147155-MONOMER"/>
<dbReference type="BRENDA" id="5.3.3.5">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807047">
<property type="pathway name" value="Cholesterol biosynthesis via desmosterol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807062">
<property type="pathway name" value="Cholesterol biosynthesis via lathosterol"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q15125"/>
<dbReference type="UniPathway" id="UPA00063"/>
<dbReference type="GenomeRNAi" id="10682"/>
<dbReference type="PRO" id="PR:Q15125"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000147155"/>
<dbReference type="CleanEx" id="HS_EBP"/>
<dbReference type="ExpressionAtlas" id="Q15125">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15125">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000247">
<property type="term" value="F:C-8 sterol isomerase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0047750">
<property type="term" value="F:cholestenol delta-isomerase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0015238">
<property type="term" value="F:drug transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004769">
<property type="term" value="F:steroid delta-isomerase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006695">
<property type="term" value="P:cholesterol biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033489">
<property type="term" value="P:cholesterol biosynthetic process via desmosterol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033490">
<property type="term" value="P:cholesterol biosynthetic process via lathosterol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008203">
<property type="term" value="P:cholesterol metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001501">
<property type="term" value="P:skeletal system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="InterPro" id="IPR007905">
<property type="entry name" value="EBP"/>
</dbReference>
<dbReference type="InterPro" id="IPR033118">
<property type="entry name" value="EXPERA"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR14207">
<property type="entry name" value="PTHR14207"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05241">
<property type="entry name" value="EBP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51751">
<property type="entry name" value="EXPERA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0898">Cataract</keyword>
<keyword id="KW-0152">Cholesterol biosynthesis</keyword>
<keyword id="KW-0153">Cholesterol metabolism</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0977">Ichthyosis</keyword>
<keyword id="KW-0413">Isomerase</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0752">Steroid biosynthesis</keyword>
<keyword id="KW-0753">Steroid metabolism</keyword>
<keyword id="KW-0756">Sterol biosynthesis</keyword>
<keyword id="KW-1207">Sterol metabolism</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="initiator methionine" description="Removed" evidence="1">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase" id="PRO_0000174342">
<location>
<begin position="2"/>
<end position="230"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="29"/>
<end position="49"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="66"/>
<end position="86"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="121"/>
<end position="141"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="2">
<location>
<begin position="185"/>
<end position="205"/>
</location>
</feature>
<feature type="domain" description="EXPERA" evidence="3">
<location>
<begin position="61"/>
<end position="204"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylthreonine" evidence="1">
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In MEND; patients have mildly increased concentrations of plasma 8(9)-cholestenol and 8-dehydrocholesterol; probable hypomorphic mutation; dbSNP:rs104894795." id="VAR_074633" evidence="9">
<original>L</original>
<variation>P</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence variant" description="In MEND; patients have increased concentrations of plasma 8(9)-cholestenol, 8-dehydrocholesterol and 7-dehydrocholesterol; probable hypomorphic mutation; dbSNP:rs587783599." id="VAR_074634" evidence="12">
<original>W</original>
<variation>C</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In MEND; patients have increased concentrations of plasma 8-dehydrocholesterol and 8(9)-cholestenol; probable hypomorphic mutation; dbSNP:rs878854359." id="VAR_074635" evidence="13">
<original>W</original>
<variation>R</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In MEND; patients have increased plasma levels of 8(9)-cholestenol; probable hypomorphic mutation; dbSNP:rs797045153." id="VAR_074636" evidence="14">
<original>I</original>
<variation>N</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In CDPX2; dbSNP:rs104894800." id="VAR_012105" evidence="5">
<original>E</original>
<variation>K</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In CDPX2." id="VAR_074637" evidence="11">
<original>E</original>
<variation>K</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In CDPX2." id="VAR_012106" evidence="4">
<original>R</original>
<variation>Q</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In CDPX2." id="VAR_012107" evidence="8">
<original>R</original>
<variation>G</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In CDPX2; dbSNP:rs28935174." id="VAR_012108" evidence="5 7 15">
<original>R</original>
<variation>H</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 35% of wild-type." evidence="17">
<original>W</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 35% of wild-type." evidence="17">
<original>I</original>
<variation>A</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 10% of wild-type." evidence="17">
<original>H</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 10% of wild-type." evidence="17">
<original>E</original>
<variation>A</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 2% of wild-type." evidence="10">
<original>Y</original>
<variation>W</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 35% of wild-type." evidence="10">
<original>M</original>
<variation>A</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on catalytic activity." evidence="10">
<original>M</original>
<variation>V</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 10% of wild-type." evidence="17">
<original>E</original>
<variation>A</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 10% of wild-type." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 35% of wild-type." evidence="17">
<original>Y</original>
<variation>A</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 35% of wild-type." evidence="10">
<original>F</original>
<variation>A</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on catalytic activity." evidence="10">
<original>F</original>
<variation>L</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 10% of wild-type." evidence="17">
<original>N</original>
<variation>A</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces catalytic activity to less than 10% of wild-type." evidence="17">
<original>W</original>
<variation>A</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAG33096." ref="2" evidence="18">
<original>FY</original>
<variation>IF</variation>
<location>
<begin position="187"/>
<end position="188"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01087"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391218"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391219"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10406945"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10942423"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11493318"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12503101"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12760743"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18176751"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20949533"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24459067"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24700572"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25814754"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8798407"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9894009"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<sequence length="230" mass="26353" checksum="3931A9DE3DBAFA04" modified="2007-01-23" version="3">
MTTNAGPLHPYWPQHLRLDNFVPNDRPTWHILAGLFSVTGVLVVTTWLLSGRAAVVPLGT
WRRLSLCWFAVCGFIHLVIEGWFVLYYEDLLGDQAFLSQLWKEYAKGDSRYILGDNFTVC
METITACLWGPLSLWVVIAFLRQHPLRFILQLVVSVGQIYGDVLYFLTEHRDGFQHGELG
HPLYFWFYFVFMNALWLVLPGVLVLDAVKHLTHAQSTLDAKATKAKSKKN
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>